Guideline for chemotherapy generics to be formulated

The Korea Food and Drug Administration is considering drafting a guideline for approval of oral chemotherapy generics, including Xeloda (Capecitabine), as part of effort to encourage local drug makers to market them within an earlier period.

To this end, the drug agency said its Central Pharmaceutical Deliberation Committee will soon determine the scope of data necessary for the product lice...